Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

16.93
BATS BZX Real-Time Price
As of 3:46pm ET
 +0.08 / +0.47%
Today’s Change
7.51
Today|||52-Week Range
25.25
+75.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues14.6M30.4M18.7M43.4M
 
 
 
 
 
Cost of Goods Sold4.7M5.7M6.1M7.7M
 
 
 
 
 
Depreciation And Amortization464.0K458.0K421.0K395.0K
 
 
 
 
 
 
Operating ExpensesGross Income9.5M24.2M12.2M35.2M
 
 
 
 
 
General Expenses28.5M28.1M26.1M31.0M
 
 
 
 
 
Research And Development19.9M19.7M16.7M21.2M
 
 
 
 
 
Total Operating Expenses33.6M34.2M32.6M39.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.0M-3.9M-13.9M4.2M
 
 
 
 
 
Interest Expense On Debt1.4M1.4M1.3M1.3M
 
 
 
 
 
Other Expenses0.00-45.0K0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.3M-5.3M-15.1M3.0M
 
 
 
 
 
Net Income-20.3M-5.3M-15.1M3.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS124.0M124.3M125.3M126.1M
 
 
 
 
 
Shares To Calculate EPS Diluted124.0M124.3M125.3M134.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.16-$0.04-$0.12$0.02
 
 
 
 
 
EPS Diluted-$0.16-$0.04-$0.12$0.02